MitchellJoshuaRossMD
Cardiology • Phoenix, AZAdult Congenital Heart Disease, Interventional Cardiology
Physician
Overview of Dr. Ross
Dr. Mitchell Ross is a cardiologist in Phoenix, AZ and is affiliated with multiple hospitals in the area, including HonorHealth Scottsdale Shea Medical Center, HonorHealth Scottsdale Osborn Medical Center, HonorHealth Sonoran Crossing Medical Center, Banner Estrella Medical Center, Banner - University Medical Center Phoenix, and St. Joseph's Hospital and Medical Center. He received his medical degree from Harvard Medical School and has been in practice 20 years. He is one of 60 doctors at Banner Estrella Medical Center and one of 121 doctors at Banner - University Medical Center Phoenix who specialize in Cardiology. He has 3 publications and over 50 citings.
Office
9250 W. Thomas Rd
Ste. 300
Phoenix, AZ 85037
Education & Training
University of Pennsylvania Health SystemFellowship, Interventional Cardiology, 2003 - 2004- University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2000 - 2003
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1997 - 2000
Harvard Medical SchoolClass of 1997
Certifications & Licensure
AZ State Medical License 2003 - 2026
MI State Medical License 2022 - 2025
PA State Medical License 2000 - 2004- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2011-2014
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 32 citationsTranscatheter device closure of interatrial septal defects in patients with hypoxia.Leonard Ilkhanoff, Srihari S. Naidu, Sameer Rohatgi, Mitchell J. Ross, Frank E. Silvestry
Journal of Interventional Cardiology. 2005-08-01 - 13 citationsCorynebacterium jeikeium Native Valve Endocarditis Following Femoral Access for Coronary AngiographyMitchell J. Ross, George Sakoulas, Warren J. Manning, William E. Cohn, Alan Lisbon
Clinical Infectious Diseases. 2001-04-01 - 23 citationsAngiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition. results from the TARGET trialMitchell J. Ross, Howard C. Herrmann, David J. Moliterno, James C. Blankenship, Laura A. Demopoulos
Journal of the American College of Cardiology. 2003-09-17
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
